Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
28 results
- D1.532 - Phenotypic and Functional Comparison of LAD2, HMC-1.2, and Primary Human Mast Cells
- D1.529 - Evaluating the Disease-Modifying Potential of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis: An Update on the Pivotal HARBOR Study
- D1.530 - Patient Experience of Most Burdensome Nonadvanced Systemic Mastocytosis Symptoms From the Pivotal Summit Trial of Bezuclastinib
- D1.531 - Avapritinib in Indolent Systemic Mastocytosis: Real-world Data from a Greek Case Series
- D1.533 - Systemic mastocytosis despite normal baseline tryptase: a diagnostic pitfall in recurrent life-threatening anaphylaxis
D2.127 - Rhinovirus Infection in Early Childhood and Risk of Asthma: A Two-Year Follow-Up Study
D2.122 - Impact of Asthma on Outcomes after out-of-hospital cardiac arrest: A nationwide pathway-based analysis, 2013-2023
D2.123 - Temporal Stability of Asthma-Related Out-of-Hospital Cardiac Arrest: A Nationwide SARIMA Analysis of Korean Data From 2013 to 2023
D2.124 - Clinical Significance of Humoral Immunodeficiency in Patients with Severe Asthma
D2.125 - When Severe Asthma Isn’t Asthma: A Case of Humoral Immunodeficiency With Suspicion of Lymphoproliferative Disease
D2.126 - Analysis of Clinical Characteristics and Airway Morphological Structure Parameters in Patients with Bronchial Asthma Combined with Bronchiectasis
D2.129 - Cardiac onset of EGPA in a postpartum woman: the importance of early diagnosis
D2.130 - Dupilumab for asthma and chronic rhinosinusitis with or without nasal polyps : A Multi-Timepoint Real-World Analysis
D2.131 - Application of a Neural Network Model for Predicting Clinical Outcomes of Acute Bronchitis with Bronchospasm Based on Comorbidities
D2.132 - Prediction of Clinical Outcomes of Acute Bronchitis with Bronchospasm Based on Trigger Factors Using a Neural Network Model
D2.133 - Assessment of growth pattern in wheezing children (3-12 years of age)
D3.17 - Outcomes of Anti-Tuberculosis Drug Reintroduction Following Adverse Drug Reactions among Adult Patients at a Tertiary Hospital in the Philippines (2022-2024)
D3.27 - Nivolumab-Induced Psoriasiform Eruption: Diagnostic Challenge Between Immune-Related Toxicity and Drug Allergy
D3.30 - Automated generation of structured clinical databases in drug hypersensitivity: real-world validation in patients with proton pump inhibitor reactions
D3.16 - Increase of Post–SARS-CoV-2 Rashes Mimicking Penicillin Allergy in Children with Group A beta-hemolytic Streptococcus Infection: an emerging and challenging issue
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download